Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ

Jonathan Douxfils; Constant Gillot; François Mullier; Julien Favresse

doi:10.1016/j.jinf.2021.08.023

Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ

Jonathan Douxfils, Constant Gillot, François Mullier, Julien Favresse

Résultats de recherche: Contribution à un journal/une revue › Lettre › Revue par des pairs

langue originale	Anglais
Pages (de - à)	e4-e5
journal	Journal of Infection
Volume	83
Numéro de publication	4
Date de mise en ligne précoce	2021
Les DOIs	https://doi.org/10.1016/j.jinf.2021.08.023
Etat de la publication	Publié - oct. 2021

SDG des Nations Unies

Ce résultat contribue à ou aux Objectifs de développement durable suivants

Accès au document

10.1016/j.jinf.2021.08.023

Autres fichiers et liens

Lien vers la publication sur Scopus

The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J. (Promoteur), Dogne, J.-M. (Co-Promoteur), FAVRESSE, J. (Co-investigateur), Tre-Hardy, M. (Co-investigateur), Mullier, F. (Co-investigateur), Haguet, H. (Chercheur), Hardy, M. (Chercheur), Melchionda, S. (Chercheur), BOUVY, C. (Chercheur), Morimont, L. (Chercheur), Gillot, C. (Chercheur), Djokoto, H. (Chercheur), Alpan, L. (Technicien), Devel, P. (Technicien), Modaffari, E. (Technicien) & Maloteau, V. (Technicien)
13/03/20 → …
Projet: Recherche

Contient cette citation

@article{6c0833a923f245288f48c13bb6b7fd44,

title = "Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ",

keywords = "COVID-19, Immunological response, SARS-CoV-2 vaccination, Seroneutralization",

author = "Jonathan Douxfils and Constant Gillot and Fran{\c c}ois Mullier and Julien Favresse",

note = "Funding Information: This research has been funded in own founds from the University of Namur.",

year = "2021",

month = oct,

doi = "10.1016/j.jinf.2021.08.023",

language = "English",

volume = "83",

pages = "e4--e5",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ

AU - Douxfils, Jonathan

AU - Gillot, Constant

AU - Mullier, François

AU - Favresse, Julien

N1 - Funding Information: This research has been funded in own founds from the University of Namur.

PY - 2021/10

Y1 - 2021/10

KW - COVID-19

KW - Immunological response

KW - SARS-CoV-2 vaccination

KW - Seroneutralization

UR - http://www.scopus.com/inward/record.url?scp=85114357350&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2021.08.023

DO - 10.1016/j.jinf.2021.08.023

M3 - Letter

C2 - 34407421

SN - 0163-4453

VL - 83

SP - e4-e5

JO - Journal of Infection

JF - Journal of Infection

IS - 4

ER -

Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ

SDG des Nations Unies

Accès au document

Autres fichiers et liens

Projets

The COVILAB project : Clinical laboratory investigations related to COVID-19

Contient cette citation